» Articles » PMID: 30970975

Biphasic Calcium Phosphate (BCP)-Immobilized Porous Poly (d,l-Lactic-co-Glycolic Acid) Microspheres Enhance Osteogenic Activities of Osteoblasts

Overview
Publisher MDPI
Date 2019 Apr 12
PMID 30970975
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to evaluate the potential of porous poly (d,l-lactic--glycolic acid) (PLGA) microspheres (PMSs) immobilized on biphasic calcium phosphate nanoparticles (BCP NPs) (BCP-IM-PMSs) to enhance osteogenic activity. PMSs were fabricated using a fluidic device, and their surfaces were modified with l-lysine (aminated-PMSs), whereas the BCP NPs were modified with heparin⁻dopamine (Hep-DOPA) to obtain heparinized⁻BCP (Hep-BCP) NPs. BCP-IM-PMSs were fabricated via electrostatic interactions between the Hep-BCP NPs and aminated-PMSs. The fabricated BCP-IM-PMSs showed an interconnected pore structure. In vitro studies showed that MG-63 cells cultured on BCP-IM-PMSs had increased alkaline phosphatase activity, calcium content, and mRNA expression of osteocalcin (OCN) and osteopontin (OPN) compared with cells cultured on PMSs. These data suggest that BCP NP-immobilized PMSs have the potential to enhance osteogenic activity.

Citing Articles

Fabrication and biological evaluation of three-dimensional (3D) Mg substituted bi-phasic calcium phosphate porous scaffolds for hard tissue engineering.

Ramadas M, Abimanyu R, Ferreira J, Ballamurugan A RSC Adv. 2022; 12(52):33706-33715.

PMID: 36505699 PMC: 9685373. DOI: 10.1039/d2ra04009c.


Therapeutic Efficacy of Intratendinous Delivery of Dexamethasone Using Porous Microspheres for Amelioration of Inflammation and Tendon Degeneration on Achilles Tendinitis in Rats.

Choi S, Song M, Shim K, Kim H, Lim Y, Song H Biomed Res Int. 2020; 2020:5052028.

PMID: 32090096 PMC: 6996678. DOI: 10.1155/2020/5052028.

References
1.
Zhang R, Ma P . Porous poly(L-lactic acid)/apatite composites created by biomimetic process. J Biomed Mater Res. 1999; 45(4):285-93. DOI: 10.1002/(sici)1097-4636(19990615)45:4<285::aid-jbm2>3.0.co;2-2. View

2.
Maquet V, Boccaccini A, Pravata L, Notingher I, Jerome R . Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. Biomaterials. 2004; 25(18):4185-94. DOI: 10.1016/j.biomaterials.2003.10.082. View

3.
Freiberg S, Zhu X . Polymer microspheres for controlled drug release. Int J Pharm. 2004; 282(1-2):1-18. DOI: 10.1016/j.ijpharm.2004.04.013. View

4.
LeGeros R, Lin S, Rohanizadeh R, Mijares D, Legeros J . Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med. 2004; 14(3):201-9. DOI: 10.1023/a:1022872421333. View

5.
Rezwan K, Chen Q, Blaker J, Boccaccini A . Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006; 27(18):3413-31. DOI: 10.1016/j.biomaterials.2006.01.039. View